MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	1	1
2022	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
TIBER CREEK GROUP	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	2
SENATE	2

Most frequently reported lobbying issues

MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS) — Lobbying Disclosure | Poliscope